HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Organ allocation for chronic liver disease: model for end-stage liver disease and beyond.

AbstractPURPOSE OF REVIEW:
Implementation of the model for end-stage liver disease (MELD) score has led to a reduction in waiting list registration and waitlist mortality. Prognostic models have been proposed to either refine or improve the current MELD-based liver allocation.
RECENT FINDINGS:
The model for end-stage liver disease - sodium (MELDNa) incorporates serum sodium and has been shown to improve the predictive accuracy of the MELD score. However, laboratory variation and manipulation of serum sodium is a concern. Organ allocation in the United Kingdom is now based on a model that includes serum sodium. An updated MELD score is associated with a lower relative weight for serum creatinine coefficient and a higher relative weight for bilirubin coefficient, although the contribution of reweighting coefficients as compared with addition of variables is unclear. The D-MELD, the arithmetic product of donor age and preoperative MELD, proposes donor-recipient matching; however, inappropriate transplantation of high-risk donors is a concern. Finally, the net benefit model ranks patients according to the net survival benefit that they would derive from the transplant. However, complex statistical models are required and unmeasured characteristics may unduly affect the model.
SUMMARY:
Despite their limitations, efforts to improve the current MELD-based organ allocation are encouraging.
AuthorsSumeet K Asrani, W Ray Kim
JournalCurrent opinion in gastroenterology (Curr Opin Gastroenterol) Vol. 26 Issue 3 Pg. 209-13 (May 2010) ISSN: 1531-7056 [Electronic] United States
PMID20224394 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Review)
Topics
  • Great Britain
  • Humans
  • Liver Diseases (surgery)
  • Liver Transplantation
  • Models, Statistical
  • Tissue and Organ Procurement (methods)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password: